![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Al-Omari WR, Al-Shammaa HB, Al-Tikriti EM, Ahmed KW. 2006. Atosiban and nifedipine in acute tocolysis: A comparative study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 128:129–134.
- Al-Qattan F, Omu A, Labeeb N. 2009. Prospective randomized study comparing nifedipine versus ritodrine for suppression of preterm labour. Medical Principles and Practice 9:164–173.
- Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD, editors. 2001. Williams obstetrics. New York: McGraw-Hill. p. 689–727.
- Ferring Pharmaceuticals Ltd. 2000. Atosiban. Summary of product characteristics. West Drayton: Ferring Pharmaceuticals Ltd.
- Goldenberg RL, Nelson KG, Davis RO, Koski J. 1984. Delay in delivery: influence of gestational age and the duration of delay on perinatal outcome. Obstetrics and Gynecology 64:480–484.
- Goomarasamy A, Knox EM, Gee H, Song F, Khan KS. 2003. Effectiveness of nifedipine versus atosiban for tocolysis in pre-term labour: a meta-analysis with an indirect comparison of randomised trials. British Journal of Obstetrics and Gynaecology 110:1045–1049.
- Gyetvai K, Hannah ME, Hodnett A. 1999. Tocolytics for pre-term labor: A systematic review. Obstetrics and Gynecology 94:869–877.
- Joseph KS, Demissie K, Kramer MS. 2002. Obstetric intervention, stillbirth, and pre-term birth. Seminars in Perinatology 26:250–259.
- Joseph KS, Kramer MS, Marcoux S, Ohlsson A, Wen SW, Allen A . 1998. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. New England Journal of Medicine 339:1434–1439.
- Kan KY, Lamont RF. 2008. Developments in the pharmacotherapeutic management of spontaneous pre-term labor. Expert Opinion on Pharmacotherapy 9:1153–1168.
- Kashanian M, Akbarian AR, Soltanzadeh M. 2005. Atosiban and nifedipine for the treatment of preterm labor. International Journal of Gynaecology and Obstetrics 91:10–14.
- Khan K, Zamora J, Lamont RF, Van Geijn H, Svare J, Santos-Jorge C . 2010. Safety concerns for the use of calcium channel blockers in pregnancy for the treatment of spontaneous preterm labour and hypertension: a systematic review and meta-regression analysis. Journal of Maternal-Fetal and Neonatal Medicine 23:1030–1038.
- King JF, Flenady V, Papatsonis D, Dekker G, Carbonne B. 2003. Calcium channel blockers for inhibiting preterm labour. Cochrane Database of Systematic Reviews(1):CD002255.
- Klam SL, Leduc L. 2004. Management options for preterm labour in Canada. Journal of Obstetrics and Gynaecology Canada 26:339–345.
- Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. 2006. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Annals of Pharmacotherapy 40:824–829.
- Mathews TJ, MacDorman MF. 2008. Infant mortality statistics from the 2005 period linked birth/infant death data set. National Vital Statistics Reports 57:1–32.
- Papatsonis D, Flenady V, Cole S, Liley H. 2010. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database of Systematic Reviews(3):CD004452.
- Romero R, Mazor M, Munoz H, Gomez R, Galasso M, Sherer MD. 1994. The preterm labor syndrome. Annals of the New York Academy of Sciences 734:414–429.
- Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B . 2000. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue. American Journal of Obstetrics and Gynecology 182:1173–1183.
- Wex J, Connolly M, Rath W. 2009. Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation. BMC Pregnancy and Childbirth 9:23.